Crohn’s & Colitis Foundation of America

Crohn’s & Colitis Foundation launch Clinical Trials Community

Monday, July 31, 2017

On July 20, 2017, the Crohn’s & Colitis Foundation launched a Clinical Trials Community (the Community) for the education of patients, family members, caregivers and healthcare providers regarding the study of irritable bowel disease (IBD). Specifically, the community will provide education on the clinical trial process as well as its value for facilitating improvements in care. Subsequently, this process may help reduce barriers to patient enrollment in IBD clinical trials, thereby enabling faster routes to therapeutic discovery.

[Read More]

Crohn’s & Colitis Foundation launches IBD Clinical Trials Community

Monday, July 24, 2017

Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across all disease states; this is especially true for inflammatory bowel diseases (IBD). The Crohn’s & Colitis Foundation launched a dedicated Clinical Trials Community for IBD. The Community is designed to educate patients, caregivers, and healthcare providers about the clinical trial process, its value, and how to address barriers that exist in enrollment.

[Read More]

CCFA, University of Pennsylvania, Nestlé collaborate on IBD study

Wednesday, March 4, 2015

The Crohn’s & Colitis Foundation of America (CCFA) has entered into a research partnership with the Perelman School of Medicine at the University of Pennsylvania and Nestlé Health Science to study the effects of diet on gut bacteria. The study is part of a major CCFA effort to develop new treatments targeting the gut microbiome—the “ecosystem” of microbes populating the intestines—linked to the development of inflammatory bowel diseases (IBD).

[Read More]

Crohn’s & Colitis Foundation, UNC expand IBD patient-focused engagement

Friday, February 20, 2015

The Crohn’s & Colitis Foundation of America (CCFA) is collaborating with the University of North Carolina School of Medicine (UNC) to create a research partnership between patients with inflammatory bowel disease (IBD) and the scientific community. CCFA Partners is a “patient-powered research network” for Crohn’s disease and ulcerative colitis (collectively known as IBD) that uses state-of-the-art bioinformatics to engage and gather information from patients that researchers can study and analyze along with clinical and other patient-generated data.

[Read More]